About CMBN

The Centre for Molecular Biology and Neuroscience (CMBN) (Senter for molekylærbiologi og nevrovitenskap) at the University of Oslo and Rikshospitalet, Oslo University Hospital is a Norwegian Centre of Excellence (Senter for fremragende forskning), appointed by the Research Council of Norway.

Objectives

The Centre shall take on a leading role in elucidating the role of DNA repair and genome maintenance mechanisms in preventing neurological disease and brain ageing. The Centre will develop and apply stem cell technology and targeted repair to broaden the range of therapeutic strategies in neurological disease.

Management

The Centre is led by Director Prof. Tone Tønjum and Assistant Director Prof. Jon Storm-Mathisen.

Former directors: Ole Petter Ottersen and Erling Seeberg.

The board

The members of the board of CMBN are:

• Professor Ole M. Sejersted, University of Oslo (Chairman)
• Director Mari Trommald, Helse Sør-Øst
• Professor Kirsten Sandvig, Rikshospitalet University Hospital
• Professor Torgeir Bruun Wyller, Ullevål University Hospital
• Professor John Torgils Vaage, University of Oslo
• Professor Lars Terenius, Karolinska Institutet

Research groups

The Centre consists of 11 research groups at the University of Oslo (UiO) and Rikshospitalet University Hospital. In total, almost 200 people are involved in the research at CMBN.

Funding

The Centre and the research groups of the Centre receive the major funding from the following organisations:

• The Research Council of Norway
• University of Oslo
• Rikshospitalet
• Helse Sør-Øst
• Norwegian Cancer Society
• European Union

Annual reports

• CMBN 10 year summary report
• CMBN Annual Report 2011
• CMBN Annual Report 2010
• CMBN Annual Report 2009
• CMBN Annual Report 2008
• CMBN Annual Report 2007
• CMBN Annual Report 2006
• CMBN Annual Report 2005
• CMBN Annual Report 2004

More information

• A booklet about CMBN is available. Contact the administration for a printed copy.
• Fact sheet about CMBN from the Research Council of Norway